Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Norton

Showing results (491-500 of 523) with videos related to

Pageof 53
Sort By:
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Open Forum Infectious Diseases|November 29, 2023
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO StudyIrene Pericot-Valverde, Snehal S Lopes, Shadi Nahvi, et al.
Journal of Psychosomatic Research|October 22, 2025
Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO studyIrene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative GroupA Thyss, S Suciu, Y Bertrand, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principleL De Mattos-Arruda, B Weigelt, J Cortes, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
Leukemia|September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group reportN Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trialF Millot, S Suciu, N Philippe, et al.
Pageof 53

Showing results (491-500 of 523) with videos related to

Sort By:
Pageof 53
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Open Forum Infectious Diseases|November 29, 2023
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO StudyIrene Pericot-Valverde, Snehal S Lopes, Shadi Nahvi, et al.
Journal of Psychosomatic Research|October 22, 2025
Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO studyIrene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative GroupA Thyss, S Suciu, Y Bertrand, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principleL De Mattos-Arruda, B Weigelt, J Cortes, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
Leukemia|September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group reportN Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trialF Millot, S Suciu, N Philippe, et al.
Pageof 53